Andrew M. Bellizzi

Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus.

Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry.

Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.

The esophageal mucosa and submucosa: immunohistology in GERD and Barrett's esophagus.

Tissue resistance in the normal and diseased esophagus.

Identification of KIT activating mutations in paediatric solitary mastocytoma.

Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (ΔNp63) in squamous cell and urothelial carcinoma.

Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms.

Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.

A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors.

Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.

Screening for Lynch syndrome: a no-brainer: BRAF V600E mutation-specific immunohistochemistry: caveat emptor.

Non-hyperfunctioning pancreatic endocrine tumors: multimodality imaging features with histopathological correlation.

Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?

Immunohistochemistry in Gastroenterohepatopancreatobiliary Epithelial Neoplasia: Practical Applications, Pitfalls, and Emerging Markers.

Serous Cystadenocarcinoma of the Pancreas: Clinical Features and Management of a Rare Tumor.

Eosinophilic esophagitis: current perspectives from diagnosis to management.

Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival.

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.

Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastases.

Re-Evaluating E-Cadherin and β-Catenin: A Pan-Cancer Proteomic Approach with an Emphasis on Breast Cancer.

The Distal Predilection of Small Bowel Neuroendocrine Tumors.

Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs).

A case of primary cutaneous Ewing sarcoma in a neutropenic patient.

The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors.